Healthcare real estate is becoming India's next institutional asset class, and the capital thesis is already forming

India's hospital infrastructure buildout is producing a distinct real estate investment thesis

For much of the past decade, India's institutional real estate capital concentrated around familiar verticals: office parks, logistics warehouses, data centers, and, more recently, co-living and senior living platforms. Each followed a recognizable arc, moving from fragmented developer-led construction to structured, yield-oriented institutional ownership. Healthcare real estate now stands at the threshold of that same transition.

The signals are unmistakable. India's healthcare sector recorded cumulative deal values exceeding USD 1.12 billion in Q2 FY26 alone, according to Grand View Research, reflecting strong investor appetite across hospitals and diagnostics. Large private hospital chains are expected to add over 34,000 beds between FY2026 and FY2030, translating to a cumulative 48–50% addition over existing capacity, with an estimated capital expenditure of Rs 40,000 crore, according to ICRA Limited. The healthcare real estate market in India is projected to reach US$ 50,727.6 million by 2030, growing at a CAGR of 9.9%, per Grand View Research.

These are not peripheral numbers. They describe a capital formation cycle comparable in scale and velocity to the logistics and data center buildouts that GRI Institute members have debated extensively across conferences and closed-door sessions over the past three years.

What distinguishes this moment is the convergence of structural demand drivers, including medical tourism growth, rising insurance penetration, and increased government health spending, with regulatory conditions specifically designed to attract institutional capital. India's FDI policy permits 100% foreign direct investment in hospitals under the automatic route, a framework that eliminates approval bottlenecks and positions healthcare infrastructure as one of the most accessible entry points for global capital seeking Indian real estate exposure.

Why does healthcare real estate require its own capital formation logic?

The temptation is to treat healthcare real estate as a subcategory of commercial property. That instinct misses the structural differences that demand a distinct investment framework.

Hospital assets carry characteristics that sit between core commercial real estate and operating businesses. Lease tenors tend to be significantly longer than office or retail, reflecting the capital-intensive fit-outs required for clinical environments and the high switching costs for hospital operators. Revenue models are hybrid, blending rental yields with operator performance, which introduces underwriting complexity absent in conventional commercial deals.

Asset specificity is another defining feature. A Grade A office building can be repositioned across tenants with modest capital expenditure. A 300-bed multi-specialty hospital, built to exacting regulatory and clinical specifications, presents a fundamentally different repositioning calculus. This specificity creates both risk and opportunity. Institutional investors willing to develop deep sectoral expertise can capture yield premiums that compensate for lower asset fungibility.

The operator model further differentiates this vertical. In logistics, the tenant-operator distinction is relatively clean. In healthcare, the relationship between the real estate owner and the hospital operator is more nuanced and consequential. Lease structures must account for bed occupancy volatility, regulatory compliance obligations, and the reputational interdependence between the physical facility and the clinical brand. Deal structuring in this space requires capabilities that blend real estate underwriting with healthcare sector knowledge, a combination that remains scarce across India's institutional investor base.

For GRI Institute members tracking alternative asset class formation, this scarcity represents a strategic window. The investors and operators who build this hybrid capability first will shape the valuation benchmarks and deal templates that define the vertical for the next decade.

How are India's institutional real estate leaders positioning for this convergence?

The broader institutional real estate ecosystem in India is already demonstrating how capital platforms can span adjacent asset classes and, in doing so, build the operational infrastructure that healthcare real estate will eventually require.

Quaiser Parvez, appointed CEO of CapitaLand Investment India in July 2026, oversees a diversified portfolio spanning business parks, warehouses, data centres, and industrial logistics, according to VCCircle. While his current mandate does not include healthcare assets, the platform architecture he manages illustrates the multi-vertical capital deployment model that healthcare real estate will likely adopt. The progression from single-asset-class platforms to diversified real asset portfolios is a pattern visible across India's maturing institutional landscape, and healthcare stands as a logical next frontier for platforms with the scale and governance frameworks to enter.

Across other verticals, similar institutional maturation is visible. Hemant Prabhu, who serves as Chief Operating Officer of Industrial & Logistics at Hiranandani Group's Greenbase platform, represents the kind of specialized operational leadership that logistics real estate developed as it transitioned from a fragmented sector to an institutional asset class. Healthcare real estate will need its own cohort of operators and capital allocators with equivalent specialization.

The residential and hospitality segments offer additional instructive parallels. Ampa Palaniappan, Managing Director of AMPA Group, recently launched Taj Sky View Hotel & Residences, a luxury branded residence project in Chennai, demonstrating how branded operating partnerships can elevate real estate positioning and attract institutional-grade capital. The branded operator model, already proven in hospitality, carries clear applicability to healthcare, where hospital brand equity directly influences asset valuation and occupancy stability.

What structural barriers must institutional capital overcome?

Despite favorable demand fundamentals and regulatory access, several structural barriers stand between healthcare real estate and full institutional asset class status in India.

First, valuation benchmarks remain nascent. Unlike office, where cap rates and rental benchmarks are established across major cities, healthcare real estate lacks standardized valuation frameworks. Institutional investors require comparable transaction data to underwrite assets confidently, and the relatively limited volume of institutional-grade healthcare real estate transactions in India means that pricing discovery is still in early stages.

Second, the regulatory environment around healthcare operations, while enabling on the FDI front, introduces compliance layers that do not exist in conventional commercial real estate. Hospital licensing, clinical quality accreditation, and state-level health regulations create an operational overlay that real estate investors must either internalize or manage through carefully structured operator partnerships.

Third, exit liquidity remains uncertain. REITs have provided a proven exit pathway for office and, increasingly, for retail and industrial assets in India. Whether healthcare assets can be aggregated into REIT-eligible portfolios, given their operational complexity and asset specificity, is a question that remains unanswered. The development of healthcare-focused investment trusts or yield vehicles will be a critical enabler for scaling institutional participation.

Fourth, talent and expertise gaps persist. The intersection of real estate capital markets knowledge and healthcare sector understanding is a narrow talent pool. Building teams capable of originating, underwriting, and managing healthcare real estate assets requires deliberate investment in human capital, a challenge that extends across investors, operators, and advisory firms.

The institutional playbook is forming

Healthcare real estate in India is not a speculative thesis. It is a capital cycle already in motion, backed by over USD 1.12 billion in quarterly deal activity, a Rs 40,000 crore multi-year capex pipeline, and a regulatory framework that explicitly welcomes foreign institutional participation.

The asset class formation logic mirrors what GRI Institute has tracked across logistics, data centers, and co-living: fragmented supply meets rising institutional demand, creating a window for first-mover platforms to establish benchmarks, structures, and operational templates.

The investors who recognize healthcare real estate as a distinct vertical, rather than a footnote within broader commercial portfolios, will define the terms on which this market institutionalizes. The capital is available. The demand is structural. The competitive advantage lies in building the specialized capabilities required to deploy effectively.

GRI Institute continues to convene India's most senior real estate and infrastructure leaders to examine precisely these emerging asset class theses. Healthcare real estate, with its convergence of demographic demand, regulatory openness, and institutional capital appetite, represents one of the most consequential strategic conversations in Indian real estate today.

As this vertical matures, the frameworks established now, in deal structuring, operator partnerships, and valuation methodology, will determine whether healthcare real estate achieves the institutional scale that India's healthcare infrastructure ambitions require.